Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial

  • Teresa MacArulla Mercadé
  • , Li Tzong Chen
  • , Chung Pin Li
  • , Jens T. Siveke
  • , David Cunningham
  • , György Bodoky
  • , Jean Frédéric Blanc
  • , Kyung Hun Lee
  • , Andrew Dean
  • , Bruce Belanger
  • , Andrea Wang-Gillam

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science